*HollyFrontier shares surge, Tesoro falls. July 30- Tesoro Corp held talks to buy smaller rival oil refiner HollyFrontier Corp earlier this year in a bid to join the top echelons of the competitive U.S. refining industry, according to people familiar with the matter. The sources did not disclose Tesoro's offer price for HollyFrontier, which has a market...» Read More
Campbell Soup Company CEO Denise Morrison, shares her consumer forecast, and discusses how her company is making products more available to consumers.
CNBC's David Faber reports Canada's Talisman Energy has agreed to be acquired by Spain's Repsol for $3.8 billion. Jim Cramer provides insight on the deal.
PetSmart has agreed to be acquired by a consortium controlled by BC partners for $8.2 billion. CNBC's Jim Cramer and David Faber break down the deal.
PetSmart agreed to sell itself to a private equity consortium for $8.7 billion, in the largest leveraged buyout of the year.
Following Merck's acquisition of Cubist, chairman and CEO Kenneth Frazier discusses innovation possibilities the deal presents for public health, with CNBC's Meg Tirrell.
Michael Lynch, Autonomy founder, discusses "accounting misrepresentations" involving Autonomy after it was sold to Hewlett-Packard back in 20111 for $11 billion.
CNBC's David Faber discusses the future of Vodafone after reports of a potential acquisition of Liberty Global surfaced in a story by Bloomberg.
The Fast Money traders discuss Twitter's potential acquisition of "Shots," the Justin Bieber backed selfie app run by John Shahidi.
Brian Whiteman, GrooveBook founder; discusses how he got the idea to start his photobook company. And Jeffrey Housenbold, Shutterfly president & CEO, shares his outlook for GrooveBook.
Discussing Shutterfly's $14.5 million acquisition of "Shark Tank" backed GrooveBook, with Brian Whiteman, GrooveBook founder; Jeffrey Housenbold, Shutterfly president & CEO, and Kevin O'Leary, "Shark Tank" investor.
AstraZeneca said it had made good progress in developing a pipeline of new drugs.
Actavis is nearing a deal to acquire Allergan in a cash and stock deal worth more than $210 per Allergan share, sources tell CNBC.
Discussing the price of Warren Buffett's acquisition of Duracell from Procter & Gamble, Nik Modi, RBC Capital Markets, explains why it seem like the perfect fit for the way Berkshire philosophically thinks about assets.
Warren Buffett is buying Duracell from Procter & Gamble. CNBC's Jim Cramer breaks down the deal.
The "Squawk Box" news team discusses Berkshire's acquisition of Duracell from Procter & Gamble.
Yahoo will acquire video advertising network Brightroll in an all-cash deal valued at $640 million.
Elliott Management sent a letter to Family Dollar's board, nominating seven new directors on Friday.
Goldman Sachs is in discussions to acquire IndexIQ, an exchange-traded fund provider, according to three sources familiar with the situation.
CNBC's David Faber reports Medtronic is changing its source of cash for its deal to buy Covidien.
Larry Van Tuyl, Van Tuyl Group, discusses the events leading up to selling his business to Warren Buffett.